EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy

Akira Kanamori, Keiichi Tominaga iD, Hironori Masuyama, Mutsumi Ishikawa, Satoshi Masuyama, Masayuki Kondo, Mimari Kanazawa, Takanao Tanaka, Masamichi Yamaura, Keiichiro Abe, Shoko Watanabe, Akira Yamamiya und 3 weitere

DEN Open · 2023-04 · 3 (1)

DOI: 10.1002/deo2.135 ↗

Kurz gefasst

Fallbericht in der Zeitschrift DEN Open, online erschienen am 05.06.2022. Verfasst von Akira Kanamori und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology Dokkyo Medical University School of Medicine Tochigi Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The patient, a 73‐year‐old woman, had been taking acid‐suppressive therapy for refractory reflux esophagitis for 10 years. A potassium‐competitive acid blocker was administered to strengthen acid‐suppressive therapy for worsening symptoms of gastroesophageal reflux disease. Esophagogastroduodenoscopy showed an increase in the number and size of fundic gland polyposis (FGPs). When acid‐suppressive therapy was changed from potassium‐competitive acid blocker to proton pump inhibitor, the FGPs showed reduced size 1 year later. Furthermore, when acid‐suppressive therapy was changed from proton pump inhibitor to histamine‐2 receptor antagonist, FGPs were even smaller after 1 and 2 years. The patient, who had no flare‐up of gastroesophageal reflux disease symptoms, continues to be treated medically with histamine‐2 receptor antagonist. This case report describes changes in endoscopic findings of a patient with FGPs caused by acid‐suppressive therapy for refractory gastroesophageal reflux disease.

Schlagwörter

Stichwörter der Autor:innen

acid‐suppressive therapyde‐escalationesophagogastroduodenoscopyfundic gland polyposis

Autor:innen und Institutionen

  • Department of Gastroenterology Dokkyo Medical University School of Medicine Tochigi Japan.
  • Masuyama Gastrointestinal Clinic Tochigi Japan.

ORCID-Profile: Keiichi Tominaga

Zitieren

APA

Kanamori, A., Tominaga, K., Masuyama, H., Ishikawa, M., Masuyama, S., Kondo, M., Kanazawa, M., Tanaka, T., Yamaura, M., Abe, K., Watanabe, S., Yamamiya, A., Abe, Y., Goda, K., & Irisawa, A. (2023). Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy. DEN Open, 3(1). https://doi.org/10.1002/deo2.135

Vancouver

Kanamori A, Tominaga K, Masuyama H, Ishikawa M, Masuyama S, Kondo M, et al. Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy. DEN Open. 2023;3(1). doi:10.1002/deo2.135

BibTeX
@article{Kanamori2023,
  author = {Kanamori, Akira and Tominaga, Keiichi and Masuyama, Hironori and Ishikawa, Mutsumi and Masuyama, Satoshi and Kondo, Masayuki and Kanazawa, Mimari and Tanaka, Takanao and Yamaura, Masamichi and Abe, Keiichiro and Watanabe, Shoko and Yamamiya, Akira and Abe, Yoko and Goda, Kenichi and Irisawa, Atsushi},
  title = {Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy},
  journal = {DEN Open},
  year = {2023},
  volume = {3},
  number = {1},
  doi = {10.1002/deo2.135}
}
Kostenlos starten →